SIGHT.PA GenSight Biologics EURONEXT 18 Mar 2026: Earnings 20 Mar, cash focus

GenSight Biologics S.A. (SIGHT.PA) trades at €0.085 on EURONEXT as we enter intraday trade on 18 Mar 2026 with earnings due on 20 Mar 2026. SIGHT.PA stock faces a binary report that may clarify cash runway and trial timelines for LUMEVOQ and GS030. Volume is elevated relative to intraday norms, and investors will key on guidance, cash burn, and partnership updates ahead of the release.